132 related articles for article (PubMed ID: 29546066)
1. Time-Dependent Effects of POT1 Knockdown on Proliferation, Tumorigenicity, and HDACi Response of SK-OV3 Ovarian Cancer Cells.
Zhou H; Mondal A; Dakic A; Alhawas L; Liu X; He Z
Biomed Res Int; 2018; 2018():7184253. PubMed ID: 29546066
[TBL] [Abstract][Full Text] [Related]
2. Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma.
Kondo T; Oue N; Yoshida K; Mitani Y; Naka K; Nakayama H; Yasui W
Cancer Res; 2004 Jan; 64(2):523-9. PubMed ID: 14744765
[TBL] [Abstract][Full Text] [Related]
3. A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes.
Escoffier E; Rezza A; Roborel de Climens A; Belleville A; Gazzolo L; Gilson E; Duc Dodon M
Retrovirology; 2005 Dec; 2():77. PubMed ID: 16354306
[TBL] [Abstract][Full Text] [Related]
4. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
Kelleher C; Kurth I; Lingner J
Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of telomere length and the expression of its regulating proteins in mesenchymal sarcomas].
Chi YK; Shen Q; Wang JC; Zheng XZ; Hou L; Zhang B
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):363-8. PubMed ID: 18677381
[TBL] [Abstract][Full Text] [Related]
6. G-quadruplex-mediated regulation of telomere binding protein POT1 gene expression.
He Q; Zeng P; Tan JH; Ou TM; Gu LQ; Huang ZS; Li D
Biochim Biophys Acta; 2014 Jul; 1840(7):2222-33. PubMed ID: 24631651
[TBL] [Abstract][Full Text] [Related]
7. Profile of POT1 as telomerase shelterin component discriminatesbetween cervical cancer and normal cervical cells.
Wijaya AB; Hidayatullah F; Setyabudhi VV; Pahlevi FR; Indra R; Nurseta T
Turk J Med Sci; 2017 Apr; 47(2):417-423. PubMed ID: 28425274
[TBL] [Abstract][Full Text] [Related]
8. MiR-185 targets POT1 to induce telomere dysfunction and cellular senescence.
Li T; Luo Z; Lin S; Li C; Dai S; Wang H; Huang J; Ma W; Songyang Z; Huang Y
Aging (Albany NY); 2020 Jul; 12(14):14791-14807. PubMed ID: 32687062
[TBL] [Abstract][Full Text] [Related]
9. Reconstitution of hTERT restores tumorigenicity in melanoma-derived c-Myc low-expressing clones.
Biroccio A; Amodei S; Benassi B; Scarsella M; Cianciulli A; Mottolese M; Del Bufalo D; Leonetti C; Zupi G
Oncogene; 2002 May; 21(19):3011-9. PubMed ID: 12082531
[TBL] [Abstract][Full Text] [Related]
10. Growth arrest in ovarian cancer cells by hTERT inhibition short-hairpin RNA targeting human telomerase reverse transcriptase induces immediate growth inhibition but not necessarily induces apoptosis in ovarian cancer cells.
Luo Y; Yi Y; Yao Z
Cancer Invest; 2009 Dec; 27(10):960-70. PubMed ID: 19909010
[TBL] [Abstract][Full Text] [Related]
11. Acidified bile acids increase hTERT expression via c-myc activation in human gastric cancer cells.
Wang X; Zhou P; Sun X; Zheng J; Wei G; Zhang L; Wang H; Yao J; Lu S; Jia P
Oncol Rep; 2015 Jun; 33(6):3038-44. PubMed ID: 25873431
[TBL] [Abstract][Full Text] [Related]
12. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
13. PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway.
Wang X; Duan W; Li X; Liu J; Li D; Ye L; Qian L; Yang A; Xu Q; Liu H; Fu Q; Wu E; Ma Q; Shen X
Oncotarget; 2015 Dec; 6(38):40959-69. PubMed ID: 26516926
[TBL] [Abstract][Full Text] [Related]
14. NFATC1 promotes cell growth and tumorigenesis in ovarian cancer up-regulating c-Myc through ERK1/2/p38 MAPK signal pathway.
Xu W; Gu J; Ren Q; Shi Y; Xia Q; Wang J; Wang S; Wang Y; Wang J
Tumour Biol; 2016 Apr; 37(4):4493-500. PubMed ID: 26501422
[TBL] [Abstract][Full Text] [Related]
15. Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors.
Zhu K; Qu D; Sakamoto T; Fukasawa I; Hayashi M; Inaba N
Arch Gynecol Obstet; 2008 Jan; 277(1):15-9. PubMed ID: 17680259
[TBL] [Abstract][Full Text] [Related]
16. c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer.
Nebbioso A; Carafa V; Conte M; Tambaro FP; Abbondanza C; Martens J; Nees M; Benedetti R; Pallavicini I; Minucci S; Garcia-Manero G; Iovino F; Lania G; Ingenito C; Belsito Petrizzi V; Stunnenberg HG; Altucci L
Clin Cancer Res; 2017 May; 23(10):2542-2555. PubMed ID: 27358484
[No Abstract] [Full Text] [Related]
17. Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours.
Schneider-Stock R; Boltze C; Jäger V; Epplen J; Landt O; Peters B; Rys J; Roessner A
J Pathol; 2003 Apr; 199(4):517-25. PubMed ID: 12635143
[TBL] [Abstract][Full Text] [Related]
18. Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
Ci X; Li B; Ma X; Kong F; Zheng C; Björkholm M; Jia J; Xu D
Oncotarget; 2015 Nov; 6(35):38079-92. PubMed ID: 26472030
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of adriamycin cytotoxicity by sodium butyrate involves hTERT downmodulation-mediated apoptosis in human uterine cancer cells.
Yu M; Kong H; Zhao Y; Sun X; Zheng Z; Yang C; Zhu Y
Mol Carcinog; 2014 Jul; 53(7):505-13. PubMed ID: 23359532
[TBL] [Abstract][Full Text] [Related]
20. Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model.
Chiu HW; Yeh YL; Wang YC; Huang WJ; Ho SY; Lin P; Wang YJ
Mol Cancer; 2016 Jun; 15(1):46. PubMed ID: 27286975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
